enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Oxymetazoline - Wikipedia

   en.wikipedia.org/wiki/Oxymetazoline

   Oxymetazoline, sold under the brand name Afrin among others, is a topical decongestant and vasoconstrictor medication. It is available over-the-counter as a nasal spray to treat nasal congestion and nosebleeds, as eye drops to treat eye redness due to minor irritation, and (in the United States) as a prescription topical cream to treat persistent facial redness due to rosacea in adults.

3. Rhinitis medicamentosa - Wikipedia

   en.wikipedia.org/wiki/Rhinitis_medicamentosa

   Rhinitis medicamentosa (or RM, also known as rebound congestion) is a condition of rebound nasal congestion suspected to be brought on by extended use of topical decongestants (e.g., oxymetazoline, phenylephrine, xylometazoline, and naphazoline nasal sprays) and certain oral medications (e.g., sympathomimetic amines and various 2-imidazolines) that constrict blood vessels in the lining of the ...

4. Nasal spray - Wikipedia

   en.wikipedia.org/wiki/Nasal_spray

   Decongestant nasal sprays are advised for short-term use only, preferably 5 to 7 days at maximum. Some doctors advise to use them 3 days at maximum. A recent clinical trial has shown that a corticosteroid nasal spray may be useful in reversing this condition. [3] Topical nasal decongestants include: Oxymetazoline; Phenylephrine; Xylometazoline

5. Anti-allergic agent - Wikipedia

   en.wikipedia.org/wiki/Anti-allergic_agent

   Decongestants help open up nasal passages thus allowing for easier breathing. Indications and route of administration. Example of oxymetazoline nasal spray. Decongestants are mainly used in conditions like common cold, allergic rhinitis, and sinusitis. They provide temporary relief from symptoms of nasal congestion.

6. Could an innovative nasal spray delay Alzheimer’s by ... - AOL

   www.aol.com/could-innovative-nasal-spray-delay...

   An experimental nasal spray has helped clear toxic protein buildups in the brains of mouse models of Alzheimer's. Its developers believe the spray may help delay Alzheimer's by at least a decade.

7. What is Neffy? FDA approves first nasal spray to treat severe ...

   www.aol.com/neffy-fda-approves-first-nasal...

   The nasal spray will officially hit the market in eight weeks. ARS Pharmaceuticals is reportedly planning to file for FDA approval for a lower-dose version of Neffy, which would work for children ...